Application of Prescription Drug Monitoring Program to detect underreported controlled substance use in patients evaluated for liver transplant
Sign Up to like & getrecommendations! Published in 2019 at "American Journal of Transplantation"
DOI: 10.1111/ajt.15548
Abstract: Presurgical controlled substance use predicts postoperative complications, increased readmissions, and mortality. We aimed to examine if a Prescription Drug Monitoring Program (PDMP) would detect underreported controlled substance use in patients undergoing liver transplant evaluation. We… read more here.
Keywords: substance; substance use; liver transplant; controlled substance ... See more keywords